{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:55:06Z","timestamp":1770288906448,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP B83C22002820006"],"award-info":[{"award-number":["CUP B83C22002820006"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clinre.2026.102764","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:13:37Z","timestamp":1768320817000},"page":"102764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-5427","authenticated-orcid":false,"given":"Giorgia","family":"Burrelli Scotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Covotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Alvaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2026.102764_bib0001","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.clinre.2026.102764_bib0002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2026.102764_bib0003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5217\/ir.2023.00039","article-title":"Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease","volume":"21","author":"Kim","year":"2023","journal-title":"Intest Res"},{"issue":"11","key":"10.1016\/j.clinre.2026.102764_bib0004","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/ibd\/izad276","article-title":"Incidence and prevalence of primary sclerosing cholangitis: a meta-analysis of population-based studies","volume":"30","author":"Cooper","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.clinre.2026.102764_bib0005","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.3390\/ijms24076660","article-title":"Role of the gut-liver axis in the pathobiology of cholangiopathies: basic and clinical evidence","volume":"24","author":"Bragazzi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2026.102764_bib0006","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/gutjnl-2023-330856","article-title":"Protective function of sclerosing cholangitis on IBD","volume":"73","author":"Bedke","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2026.102764_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0008","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ibd\/izad137","article-title":"A gradient of intestinal inflammation in primary sclerosing cholangitis","volume":"30","author":"Wittek","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2026.102764_bib0009","doi-asserted-by":"crossref","unstructured":"Barberio B, Massimi D, Cazzagon N, et al. Gastroenterology. 2021 Dec;161(6):1865-1877.","DOI":"10.1053\/j.gastro.2021.08.032"},{"issue":"4","key":"10.1016\/j.clinre.2026.102764_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.clinre.2026.102764_bib0011","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOG.0000000000000336","article-title":"Immunogenetics in primary sclerosing cholangitis","volume":"33","author":"Chung","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0012","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"7937","key":"10.1016\/j.clinre.2026.102764_bib0013","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41586-022-05308-6","article-title":"Identification of environmental factors that promote intestinal inflammation","volume":"611","author":"Sanmarco","year":"2022","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.clinre.2026.102764_bib0014","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.clinre.2026.102764_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"issue":"10","key":"10.1016\/j.clinre.2026.102764_bib0016","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.13154","article-title":"A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease","volume":"41","author":"Eaton","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clinre.2026.102764_bib0017","article-title":"ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome","volume":"4","author":"Biyoukar","year":"2022","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.clinre.2026.102764_bib0018","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102764_bib0019","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2026.102764_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102764_bib0021","doi-asserted-by":"crossref","first-page":"jjae131","DOI":"10.1093\/ecco-jcc\/jjae131","article-title":"Integrin \u03b1V\u03b26: autoantigen and driver of epithelial remodeling in colon and bile ducts in primary sclerosing cholangitis and inflammatory bowel disease","volume":"19","author":"Roth","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2026.102764_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241251600","article-title":"Biomarkers in inflammatory bowel disease: a practical guide","volume":"17","author":"Clough","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"issue":"12","key":"10.1016\/j.clinre.2026.102764_bib0024","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/apt.17988","article-title":"Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission","volume":"59","author":"Aliu","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.clinre.2026.102764_bib0022","doi-asserted-by":"crossref","first-page":"e3510","DOI":"10.1097\/MD.0000000000003510","article-title":"Evaluation of biliary calprotectin as a biomarker in primary sclerosing cholangitis","volume":"95","author":"Gauss","year":"2016","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/flgastro-2021-102053","article-title":"Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease","volume":"13","author":"Pavlidis","year":"2022","journal-title":"Frontline Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinre.2026.102764_bib0026","article-title":"Surrogate markers of bile duct disease progression in primary sclerosing cholangitis - a prospective study with repeated ERCP examinations","volume":"6","author":"F\u00e4rkkil\u00e4","year":"2024","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.clinre.2026.102764_bib0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinre.2019.05.005","article-title":"Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study","volume":"44","author":"Rauber","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102764_bib0028","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clinre.2026.102764_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13643-018-0699-4","article-title":"Registration of systematic reviews in PROSPERO: 30,000 records and counting","volume":"7","author":"Page","year":"2018","journal-title":"Syst Rev"},{"key":"10.1016\/j.clinre.2026.102764_bib0030","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm [cited 2025 Mar 8]."},{"issue":"5","key":"10.1016\/j.clinre.2026.102764_bib0031","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","author":"R\u00fchlemann","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"S1","key":"10.1016\/j.clinre.2026.102764_bib0032","doi-asserted-by":"crossref","first-page":"i400","DOI":"10.1093\/ecco-jcc\/jjac190.0380","article-title":"P250 The impact of primary sclerosing cholangitis (PSC) on fecal calprotectin assessment in individuals with inflammatory bowel disease (IBD)","volume":"17","author":"Arar","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"12","key":"10.1016\/j.clinre.2026.102764_bib0033","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ecco-jcc\/jjae096","article-title":"Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile","volume":"18","author":"Leibovitzh","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2026.102764_bib0034","article-title":"Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis","volume":"245","author":"Matysik","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102764_bib0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cgh.2018.01.020","article-title":"Symptoms do not correlate with findings from colonoscopy in children with inflammatory bowel disease and primary sclerosing cholangitis","volume":"16","author":"Ricciuto","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2026.102764_bib0036","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1042\/CS20256078","article-title":"Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitis","volume":"138","author":"Santos","year":"2025","journal-title":"Clin Sci"},{"issue":"11","key":"10.1016\/j.clinre.2026.102764_bib0037","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4253\/wjge.v16.i11.607","article-title":"Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis","volume":"16","author":"Wohl","year":"2024","journal-title":"World J Gastrointest Endosc"},{"issue":"11","key":"10.1016\/j.clinre.2026.102764_bib0038","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.cgh.2015.05.038","article-title":"Level of fecal calprotectin correlates with endoscopic and histologic inflammation and identifies patients with mucosal healing in ulcerative colitis","volume":"13","author":"Theede","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0039","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/jcm14062098","article-title":"Performance of the Mayo risk score in predicting transplant and mortality in a single-center U.S. Cohort of primary sclerosing cholangitis","volume":"14","author":"Kahan","year":"2025","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.clinre.2026.102764_bib0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/life15091412","article-title":"Microbiota and gut inflammatory markers (Zonulin and Fecal Calprotectin) exhibit age-dependent variation in patients with ulcerative colitis","volume":"15","author":"Merino","year":"2025","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.clinre.2026.102764_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14111","article-title":"Systematic review of the role of calprotectin in cirrhosis","volume":"54","author":"Fortuny","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0042","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12664-023-01481-2","article-title":"Fecal calprotectin in cirrhosis-does \"ESR\" of the intestine measure the liver dysfunction too?","volume":"42","author":"Jena","year":"2023","journal-title":"Indian J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102764_bib0043","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/j.gastro.2024.06.032","article-title":"Gut pathobiont-derived outer membrane vesicles drive liver inflammation and fibrosis in primary sclerosing cholangitis-associated inflammatory bowel disease","volume":"167","author":"Dorner","year":"2024","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2026.102764_bib0044","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.31311","article-title":"The role of the intestine in the pathogenesis of primary sclerosing cholangitis: evidence and therapeutic implications","volume":"72","author":"Dean","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2026.102764_bib0045","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered gut microbial metabolism of essential nutrients in primary Sclerosing cholangitis","volume":"160","author":"Kummen","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2026.102764_bib0046","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.clinre.2026.102764_bib0047","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/biomedicines13092179","article-title":"Fecal calprotectin and segmental inflammation in small bowel Crohn's Disease: a capsule endoscopy-based study","volume":"13","author":"Souto","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.clinre.2026.102764_bib0048","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/HEP.0000000000001236","article-title":"PSC and colitis: a complex relationship","volume":"82","author":"Horst","year":"2025","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:37:42Z","timestamp":1770237462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2210740126000112"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102764","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102764"}}